Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
International Journal of Molecular Sciences|March 28, 2026
Targeting Glutaminase Isoforms GLS and GLS2 in Luminal Breast CancerBrendah K Masisi, Rokaya El Ansari, Ali Fakroun, et al.
Histopathology|October 10, 2019
The role of glutaminase in cancerBrendah K Masisi, Rokaya El Ansari, Lutfi Alfarsi, et al.
Histopathology|August 4, 2017
Altered glutamine metabolism in breast cancer; subtype dependencies and alternative adaptationsRokaya El Ansari, Alan McIntyre, Madeleine L Craze, et al.
Histopathology|May 6, 2020
The prognostic significance of ALDH1A1 expression in early invasive breast cancerMaryam Althobiti, Rokaya El Ansari, Mohammed Aleskandarany, et al.
British Journal of Cancer|December 11, 2019
Enhanced glutamine uptake influences composition of immune cell infiltrates in breast cancerRokaya El Ansari, Madeleine L Craze, Maryam Althobiti, et al.
Breast Cancer Research and Treatment|March 23, 2020
The solute carrier SLC7A8 is a marker of favourable prognosis in ER-positive low proliferative invasive breast cancerRokaya El Ansari, Lutfi Alfarsi, Madeleine L Craze, et al.
BMC Cancer|May 16, 2020
PPFIA1 expression associates with poor response to endocrine treatment in luminal breast cancerLutfi H Alfarsi, Rokaya El Ansari, Madeleine L Craze, et al.
British Journal of Cancer|March 17, 2018
The multifunctional solute carrier 3A2 (SLC3A2) confers a poor prognosis in the highly proliferative breast cancer subtypesRokaya El Ansari, Madeleine L Craze, Maria Diez-Rodriguez, et al.
Breast Cancer Research and Treatment|September 1, 2019
CDC20 expression in oestrogen receptor positive breast cancer predicts poor prognosis and lack of response to endocrine therapyLutfi H Alfarsi, Rokaya El Ansari, Madeleine L Craze, et al.
Pageof 3